e.g. Tata motors, Reliance MF, 500570

Remus Pharmaceuticals Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 79.16 63.50 45.03 24.72 18.42
Expenses
Material consumed 35.04 27.83 21.44 12.27 11.49
Manufacturing expenses - - - - -
Personnel expenses 9.17 6.56 5.47 3.49 3.00
Selling expenses - - - - -
Adminstrative expenses 8.97 9.06 7.57 4.89 3.17
Expenses capitalised - - - - -
Cost of sales 53.18 43.45 34.48 20.65 17.66
Operating profit 25.98 20.04 10.55 4.07 0.76
Other recurring income 2.91 3.69 1.58 0.72 0.81
Adjusted PBDIT 28.89 23.74 12.12 4.79 1.57
Financial expenses 0.38 0.32 0.23 0.09 0.04
Depreciation 1.87 0.90 0.48 0.15 0.18
Other write offs - - - - -
Adjusted PBT 26.64 22.52 11.41 4.55 1.36
Tax charges 6.74 5.71 2.91 1.16 0.33
Adjusted PAT 19.90 16.82 8.50 3.39 1.03
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 19.90 16.82 8.50 3.39 1.03
Earnigs before appropriation 49.71 30.71 14.08 6.42 3.04
Equity dividend 1.18 0.59 - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 48.53 30.12 14.08 6.42 3.04
Close
Add Remus Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Remus Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback